aminolevulinic acid has been researched along with B16 Melanoma in 20 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present research work describes the use of photodynamic therapy (PDT) of drug 5-aminolevulinic acid (5-ALA) conjugated with microbial synthesised silver nanoparticles on skin melanoma (B16F10) and epidermoid carcinoma (A431) cell lines." | 7.91 | Photodynamic therapy on skin melanoma and epidermoid carcinoma cells using conjugated 5-aminolevulinic acid with microbial synthesised silver nanoparticles. ( Sanjay, KR; Shivashankarappa, A, 2019) |
| "Silver nanoparticles were synthesised using the bacterial strain Bacillus licheniformis." | 5.51 | Photodynamic therapy on skin melanoma and epidermoid carcinoma cells using conjugated 5-aminolevulinic acid with microbial synthesised silver nanoparticles. ( Sanjay, KR; Shivashankarappa, A, 2019) |
| "The present research work describes the use of photodynamic therapy (PDT) of drug 5-aminolevulinic acid (5-ALA) conjugated with microbial synthesised silver nanoparticles on skin melanoma (B16F10) and epidermoid carcinoma (A431) cell lines." | 3.91 | Photodynamic therapy on skin melanoma and epidermoid carcinoma cells using conjugated 5-aminolevulinic acid with microbial synthesised silver nanoparticles. ( Sanjay, KR; Shivashankarappa, A, 2019) |
| "Silver nanoparticles were synthesised using the bacterial strain Bacillus licheniformis." | 1.51 | Photodynamic therapy on skin melanoma and epidermoid carcinoma cells using conjugated 5-aminolevulinic acid with microbial synthesised silver nanoparticles. ( Sanjay, KR; Shivashankarappa, A, 2019) |
| "CT26 colon carcinoma and B16 melanoma cells were incubated with ALA for 48 h." | 1.31 | Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitizer. ( Greenberg, R; Haddad, R; Kaplan, O; Kashtan, H; Siegal, A; Skornick, Y, 2000) |
| "Photosensitization of the B16 melanoma cells containing high PP concentrations was effective even at low light doses." | 1.29 | Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. ( Babushkin, T; Malik, Z; Mamet, R; Nordenberg, Y; Schoenfeld, N; Shafran, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, J | 2 |
| Nagasawa, S | 1 |
| Ikemoto, MJ | 1 |
| Sato, C | 1 |
| Sato, M | 1 |
| Iwahashi, H | 2 |
| Fan, H | 2 |
| Hu, Z | 2 |
| Wang, S | 2 |
| Wu, W | 1 |
| Liu, X | 1 |
| Geng, H | 1 |
| Hu, X | 1 |
| Que, W | 1 |
| Hirano, H | 1 |
| Wang, Z | 1 |
| Nozawa, N | 1 |
| Ishii, T | 1 |
| Ishizuka, M | 1 |
| Ito, H | 1 |
| Takahashi, K | 1 |
| Nakajima, M | 1 |
| Tanaka, T | 1 |
| Zhu, P | 1 |
| Guo, WZ | 1 |
| Li, XK | 1 |
| Murakami, M | 1 |
| Mori, T | 1 |
| Souza, RKF | 1 |
| Carvalho, ICS | 1 |
| Costa, CGDCM | 1 |
| da Silva, NS | 1 |
| Pacheco-Soares, C | 1 |
| Peng, Y | 1 |
| Jia, L | 1 |
| Cao, W | 2 |
| Zheng, J | 2 |
| Shivashankarappa, A | 1 |
| Sanjay, KR | 1 |
| Lv, G | 1 |
| Zhou, Q | 1 |
| Yang, B | 1 |
| Tahmasebi, H | 1 |
| Khoshgard, K | 1 |
| Sazgarnia, A | 1 |
| Mostafaie, A | 1 |
| Eivazi, MT | 1 |
| Krestyn, E | 1 |
| Kolarova, H | 1 |
| Bajgar, R | 1 |
| Tomankova, K | 1 |
| Chen, P | 1 |
| Jiang, X | 1 |
| Wei, DP | 1 |
| Li, L | 1 |
| Sakai, M | 1 |
| Fujimoto, N | 1 |
| Ishii, K | 1 |
| Nakamura, H | 1 |
| Kaneda, Y | 1 |
| Awazu, K | 1 |
| Sparsa, A | 1 |
| Bellaton, S | 1 |
| Naves, T | 1 |
| Jauberteau, MO | 1 |
| Bonnetblanc, JM | 1 |
| Sol, V | 1 |
| Verdier, M | 1 |
| Ratinaud, MH | 1 |
| Juzenas, P | 1 |
| Juzeniene, A | 1 |
| Stakland, S | 1 |
| Iani, V | 1 |
| Moan, J | 1 |
| Haddad, R | 1 |
| Kaplan, O | 1 |
| Greenberg, R | 1 |
| Siegal, A | 1 |
| Skornick, Y | 1 |
| Kashtan, H | 1 |
| Babilas, P | 1 |
| Schacht, V | 1 |
| Liebsch, G | 1 |
| Wolfbeis, OS | 1 |
| Landthaler, M | 1 |
| Szeimies, RM | 1 |
| Abels, C | 1 |
| Ickowicz Schwartz, D | 1 |
| Gozlan, Y | 1 |
| Greenbaum, L | 1 |
| Babushkina, T | 1 |
| Katcoff, DJ | 1 |
| Malik, Z | 2 |
| Córdoba, F | 1 |
| Braathen, LR | 1 |
| Weissenberger, J | 1 |
| Vallan, C | 1 |
| Kato, M | 1 |
| Nakashima, I | 1 |
| Weis, J | 1 |
| von Felbert, V | 1 |
| Schoenfeld, N | 1 |
| Mamet, R | 1 |
| Nordenberg, Y | 1 |
| Shafran, M | 1 |
| Babushkin, T | 1 |
| Li, B | 1 |
| Zhang, X | 1 |
| Lu, Y | 1 |
| Zhao, L | 1 |
| Guo, Y | 1 |
| Guo, S | 1 |
| Kang, Q | 1 |
| Liu, J | 1 |
| Dai, L | 1 |
| Zhang, L | 1 |
| Fan, D | 1 |
| Ji, Z | 1 |
20 other studies available for aminolevulinic acid and B16 Melanoma
| Article | Year |
|---|---|
Verification of 5-Aminolevurinic Radiodynamic Therapy Using a Murine Melanoma Brain Metastasis Model.
Topics: Aminolevulinic Acid; Animals; Brain Neoplasms; Melanoma, Experimental; Mice | 2019 |
5-aminolevulinic-acid-mediated sonodynamic therapy improves the prognosis of melanoma by inhibiting survivin expression.
Topics: Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Down- | 2020 |
5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Animals; B7-H1 Antigen; Cell Line, Tumor; Citric Acid; | 2021 |
Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model.
Topics: Aminolevulinic Acid; Animals; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Particle Accelerator | 2018 |
Alteration of Surface Glycoproteins After Photodynamic Therapy.
Topics: Aminolevulinic Acid; Animals; Cell Line, Tumor; Hematoporphyrins; Lectins; Melanoma, Experimental; M | 2018 |
Sonodynamic therapy improves anti‑tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Biomarkers, Tumor; CD8-Positive T-Lymphocytes; Cell Prolife | 2018 |
Photodynamic therapy on skin melanoma and epidermoid carcinoma cells using conjugated 5-aminolevulinic acid with microbial synthesised silver nanoparticles.
Topics: Aminolevulinic Acid; Animals; Bacillus licheniformis; Carcinoma, Squamous Cell; Cell Line, Tumor; Hu | 2019 |
5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.
Topics: Aminolevulinic Acid; Animals; Cell Line, Tumor; Elasticity Imaging Techniques; Melanoma, Experimenta | 2015 |
Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
Topics: Aminolevulinic Acid; Antimetabolites, Antineoplastic; Cell Line, Tumor; Drug Synergism; Drug Therapy | 2016 |
Photodynamic properties of ZnTPPS(4), ClAlPcS(2) and ALA in human melanoma G361 cells.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Coloring Agents; DNA Fragmentation; Dose-Response Relationshi | 2010 |
[The effects of intense pulsed light and 5-aminolevulinic acid on the cultured B16 marine melanoma cells].
Topics: Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Proliferation; Melanins; Melanoma, Experimental | 2010 |
In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Delivery | 2012 |
Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspase | 2013 |
Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice.
Topics: Administration, Topical; Alamethicin; Aminolevulinic Acid; Animals; Cell Division; Hutchinson's Mela | 2002 |
Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitizer.
Topics: Aminolevulinic Acid; Animals; Colonic Neoplasms; Disease Models, Animal; Female; Melanoma, Experimen | 2000 |
Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo.
Topics: Aminolevulinic Acid; Animals; Cricetinae; Dose-Response Relationship, Radiation; Light; Melanoma, Ex | 2003 |
Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.
Topics: Acetamides; Aminolevulinic Acid; Animals; Antineoplastic Agents; Blotting, Western; Butyrates; Cell | 2004 |
5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma.
Topics: Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Fibrosis; Flo | 2005 |
Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation.
Topics: Allylisopropylacetamide; Aminolevulinic Acid; Animals; Cell Death; Dicarbethoxydihydrocollidine; Dim | 1994 |
Protein 4.1R affects photodynamic therapy for B16 melanoma by regulating the transport of 5-aminolevulinic acid.
Topics: Aminolevulinic Acid; Animals; Biological Transport; Cell Line, Tumor; Cytoskeletal Proteins; Gene Kn | 2021 |